Filing Flows › Biolife Solutions (BLFS) › Stock forecast & fair value
Biolife Solutions (BLFS) stock forecast and price target
Biolife Solutions (BLFS) trades at $38.61. The analysts' price target is $31.00 (-20%).
Biolife Solutions' latest quarter
Biolife Solutions, Q2 2026: revenue $28.5M (+22% year over year), operating margin 6.0%, net earnings $45.1M, operating cash flow $6.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for BLFS stock?
The analysts' 12-month target is $31.00, -20% from $38.61. The average rating is hold.
Does Biolife Solutions usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is BLFS stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.